• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Leukemia & Lymphoma 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Leukemia & Lymphoma trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing Leukemia & Lymphoma research

Oncology studies – such as leukemia and lymphoma – often involve multiple cohorts, various tumor types, numerous sites, and expensive medications. More importantly, patients face debilitating symptoms that can make participation difficult. That’s where Signant SmartSignals solutions can help. Our digital tools create a patient-centric clinical trial experience while helping you generate high-quality evidence.

Why Signant Health

  • Get Started in Just 8 Weeks
  • Keep Patients Engaged
  • Gain Richer Insights
  • Simplify the Consent Process
  • Optimize Supply Management
  • Offer Flexible Options
  • Get Started in Just 8 Weeks

    Get Started in Just 8 Weeks

    We created a pre-configured eCOA solution that incorporates pre-validated library instruments, scientific design best practices, oncology-specific features, as well as our unrivaled global logistics and support. It's 33% faster than other eCOA options and will reduce your costs by 20%.
     

  • Keep Patients Engaged

    Keep Patients Engaged

    Our Patient Engagement solution, a component of our eCOA solution, reminds patients of upcoming requirements, outlines each visit, and lets patients visit the sites remotely.
     

  • Gain Richer Insights

    Gain Richer Insights

    By integrating Actigraph sensors and wearables with our eCOA solution, you’ll gain a continuous, real-time view of each patients’ health status and collect objective data on sleep and activity patterns. The additional data will enhance your understanding of the post-treatment recovery associated with each treatment cycle.
     

  • Simplify the Consent Process

    Simplify the Consent Process

    Our eConsent solution uses engaging multimedia to convey complex study information and permits patients to flag sections they need further clarification on. The digital tool efficiently handles the multiple consents and protocol amendments common in oncology trials, limiting the risk of audit findings.

    Choose between a simplified, PDF-based consent form and a fully interactive, multimedia consent experience to fit your specific study needs.

  • Optimize Supply Management

    Optimize Supply Management

    Signant’s RTSM solution uses proprietary algorithms to optimize drug supplies for the complex study designs common in leukemia and lymphoma cancer trials. It also applies randomization adaptations seamlessly and protects the study’s blind.
     

  • Offer Flexible Options

    Offer Flexible Options

    Telemedicine can replace in-person visits with convenient video consultations, reducing travel burdens. This can be particularly helpful for visits that do not require in-person examinations or tests.
     

Comprehensive Leukemia & Lymphoma experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Leukemia & Lymphoma trial resources
SOLUTION BROCHURE

Leukemia & Lymphoma Trial Solutions Overview


GET INSIGHTS
VIDEO

Leukemia & Lymphoma Trial Solutions


WATCH [2 MIN]
SOLUTION

Oncology Clinical Trial Solutions


LEARN MORE

Solutions for Leukemia & Lymphoma trials

Ready to learn more?

Discover how Signant can support your current or upcoming leukemia and lymphoma trials. 

DOWNLOAD BROCHURE GET STARTED